Details werden geladen...
PBS dispute could leave MS patients with huge bills for crucial drugs Ocrevus and Kesimpta - ABC News
The latest PBS stoush with drugmakers means thousands of people with MS are at risk of being forced to pay $33,000 a year for lifesaving medication.